INFLUENCE OF TIME OF ADMINISTRATION ON VERAPAMIL PHARMACOKINETICS

被引:21
作者
HLA, KK
LATHAM, AN
HENRY, JA
机构
[1] GUYS HOSP,POISONS UNIT,LONDON SE1 9RT,ENGLAND
[2] KNOLL LTD,MAIDENHEAD,ENGLAND
关键词
D O I
10.1038/clpt.1992.35
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The plasma concentration-time profile of verapamil was studied in eight healthy drug-free volunteers after oral administration of a single 80 mg dose of the drug on six separate occasions at different times of day (4 AM, 8 AM, noon, 4 PM, 8 PM, and midnight). The median maximum plasma concentration of verapamil was significantly higher after the 8 Am and noon administrations (p < 0.05) than at any other time. The median area under the concentration-time curve was also significantly higher (p < 0.05) after administration at 8 AM and noon than at other times. The median time to maximum concentration was not significantly different at any time point (p > 0.05). It is possible that concentration-related adverse effects of verapamil could be avoided by choosing the time of day when the drug is prescribed. This concept may also apply to other drugs that have circadian effects in their pharmacokinetic profiles.
引用
收藏
页码:366 / 370
页数:5
相关论文
共 47 条
[1]   VERAPAMIL IN THE TREATMENT OF HYPERTENSION [J].
ANAVEKAR, SN ;
CHRISTOPHIDIS, N ;
LOUIS, WJ ;
DOYLE, AE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (02) :287-292
[2]   INFLUENCE OF PHARMACOKINETIC DIURNAL-VARIATION ON BIOAVAILABILITY ESTIMATES [J].
BAUER, LA ;
GIBALDI, M ;
VESTAL, RE .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :184-187
[3]   VALPROIC ACID CLEARANCE - UNBOUND FRACTION AND DIURNAL-VARIATION IN YOUNG AND ELDERLY ADULTS [J].
BAUER, LA ;
DAVIS, R ;
WILENSKY, A ;
RAISYS, V ;
LEVY, RH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (06) :697-700
[4]  
BURNMURDOCH R, 1980, J PHYSIOL-LONDON, V302, P395
[5]  
CAROSELLA L, 1979, CHRONOPHARMACOLOGY, P125
[6]   CIRCADIAN CHANGES IN THE BIOAVAILABILITY AND EFFECTS OF INDOMETHACIN IN HEALTHY-SUBJECTS [J].
CLENCH, J ;
REINBERG, A ;
DZIEWANOWSKA, Z ;
GHATA, J ;
SMOLENSKY, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (05) :359-369
[7]  
CLENCH J, 1975, CHRONOBIOLOGIA S1, V2, P14
[8]   RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE MEASUREMENT OF VERAPAMIL AND NORVERAPAMIL IN BLOOD-PLASMA OR SERUM [J].
COLE, SCJ ;
FLANAGAN, RJ ;
JOHNSTON, A ;
HOLT, DW .
JOURNAL OF CHROMATOGRAPHY, 1981, 218 (1-3) :621-629
[9]   PHYSIOLOGICAL AND PHARMACOLOGICAL VARIABILITY IN ESTIMATED HEPATIC BLOOD-FLOW IN MAN [J].
DANESHMEND, TK ;
JACKSON, L ;
ROBERTS, CJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :491-496
[10]  
DECOURT S, 1982, BRIT J CLIN PHARMACO, V13, P567